TRUTH TALK NEWS: EXPOSING the MEDICAL MAFIA
TRUTH TALK NEWS: EXPOSING THE MEDICAL MAFIA – Please WATCH this CRITICAL BROADCST despite occasional streaming/skype/ computer hacks courtesy of cointelpro. Broadcast LIVE Tuesday, July 18, 2012 on TruthBroadcastNetwork.com Host Howard Nema exposes the medical mafia and the Rockefeller bankster controlled cancer racket via research by Eustace Mullins’ work,”Murder by Injection”. Also a discussion about Sheng Wang, a Boston University cancer scientist who FABRICATED his findings for the Medical Mafia. His work was published in two journals in 2009, and he’s been ordered to retract them. But important studies by other scientists like those at the Mayo Clinic, who based their work on his findings, could now make 10 years of their studies worthless. The cancer industrial complex is a highly lucrative, well-oiled machine that tends to support funding for expensive drug treatments that don’t address the cause of the problem, and have yet to make a significant dent in the decrease of the overall cancer rate in the US despite investing hundreds of billions of dollars. Much support comes from flawed and biased “research” studies that support the use of expensive drugs as detailed in the featured articles. Researchers, too, are well aware of the notoriety and money to be found in cancer research — particularly what may be deemed successful cancer research (which unfortunately is often measured by the discovery of new drug treatments). As with many areas of medical research, it’s important to read between the lines of …
Novartis drug Afinitor wins EU nod to treat breast cancer
Filed under: drug treatment news articles
Home>Featured Articles>Breast Cancer … Afinitor, also known as everolimus, is designed to be given in combination with another drug, Aromasin, to treat women whose cancer has recurred or progressed after treatment with two other therapies. Aromasin …
Read more on Chicago Tribune
Medigene's drug VeregenR Receives Marketing Authorization in Israel …
Filed under: drug treatment news articles
Medigene AG (MDG, Frankfurt, Prime Standard) announced today that Veregen R for the treatment of genital warts has obtained marketing authorization in Israel, Denmark and Slovakia. Market launch of Veregen R in Denmark, Norway and Sweden by Medigene's …
Read more on Reuters